Condition
Platelet Thrombus
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 4 (2)
Trial Status
Completed3
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03255928Recruiting
Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)
NCT06298682RecruitingPrimary
Characterization of Exosomes Platelets-released
NCT03188705Phase 4Completed
CES1 Carriers in the PAPI Study
NCT01951001Phase 4Completed
Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome
NCT03866265Not ApplicableCompletedPrimary
Anti-Inflammatory and Anti-Coagulant Effects of Salmon Polar Lipids
Showing all 5 trials